Abstract
PPHN should be recognized as a clinical condition associated with a number of pulmonary and systemic diseases. Present therapy has resulted in increased survival, but the aggressive methods required to produce improvement necessitate a clear understanding of the underlying pathophysiology in order to minimize sequelae.
MeSH terms
-
Cardiac Catheterization
-
Combined Modality Therapy
-
Diagnosis, Differential
-
Echocardiography
-
Heart Defects, Congenital / diagnosis
-
Humans
-
Hyperventilation / diagnosis
-
Infant, Newborn
-
Oxygen / blood
-
Persistent Fetal Circulation Syndrome / diagnosis*
-
Persistent Fetal Circulation Syndrome / physiopathology
-
Persistent Fetal Circulation Syndrome / therapy
-
Prognosis
-
Respiration, Artificial
-
Vasodilator Agents / therapeutic use
Substances
-
Vasodilator Agents
-
Oxygen